Acute effect of sildenafil on hypoxemic patients (excluding those with Eisenmenger syndrome) with incurable congenital heart disease and disturbed pulmonary vasculature in the mid-term follow-up.
Yoshihide
Y
Mitani
Hiroyuki
H
Ohashi
Shin
S
Takabayashi
Hideto
H
Shimpo
Yoshihiro
Y
Komada
D002648:Child; D004541:Eisenmenger Complex; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000188:drug therapy*; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy*; D007223:Infant; D008297:Male; D010100:Oxygen / Q000097:blood; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D011651:Pulmonary Artery / Q000002:abnormalities* / Q000187:drug effects; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*
D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate; D010100:Oxygen